Ann: CEO Appointment and Resignation, page-49

Firstly, this is your money and you need to make your own decisions around it so all good. However, this is also a public forum and peoples opinions do manage to influence investors so this is worth a discussion. What is it that you asked of management? How has the company changed direction?

Rats fleeing? I see low volume and impatient retail selling. This is bio-tech for goodness sake. Kid investors nowadays have a 2 week attention span and seem to expect to be rich by the end of it. Some zooming out is needed. For starters, a decent starting portion of the companies fortunes have been handed off to Kyocera and we are still sitting at a market cap of $30mil!?!? It seems every man and his or her dog on HotCopper wants to blame market movements on management when in effect it is the normal ebb and flow of retail and general market activity (amplified by the longer tail for bio/med stock I would suggest).

Each to their own of course.